venetoclax
roche,abbvie
['leusm', 'venetoclax']
congress #eha22 | presented efficacy and safety results from a phase ii study of mini-hyper cvd + venetoclax in adult pts with r/r ph-ve b- or t-all. n=20. orr=63% (32% mrd-), cr/cri=50%, no grade 4/5 ae reported #allsm #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm